Small cap stocks poised to benefit from the Fed’s cutting cycle
Seeking Alpha News (Fri, 19-Dec 4:24 PM ET)
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
Business Wire (Fri, 5-Dec 8:00 AM ET)
CONMED Corporation Announces Third Quarter 2025 Financial Results
Business Wire (Wed, 5-Nov 4:05 PM ET)
CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025
Business Wire (Thu, 2-Oct 4:05 PM ET)
CONMED Corporation Sees Premarket Decline Following Financial Results
Market Chameleon (Thu, 6-Feb 3:34 AM ET)
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Conmed trades on the NYSE stock market under the symbol CNMD.
As of December 22, 2025, CNMD stock price climbed to $40.30 with 203,794 million shares trading.
CNMD has a beta of 0.66, meaning it tends to be less sensitive to market movements. CNMD has a correlation of 0.09 to the broad based SPY ETF.
CNMD has a market cap of $1.25 billion. This is considered a Small Cap stock.
Last quarter Conmed reported $338 million in Revenue and $1.08 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.03.
In the last 3 years, CNMD traded as high as $138.47 and as low as $38.32.
The top ETF exchange traded funds that CNMD belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.
CNMD has underperformed the market in the last year with a return of -41.1%, while the SPY ETF gained +18.8%. In the last 3 month period, CNMD fell short of the market, returning -19.4%, while SPY returned +3.5%. However, in the most recent 2 weeks CNMD has outperformed the stock market by returning +0.6%, while SPY returned +0.2%.
CNMD support price is $38.84 and resistance is $41.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNMD shares will trade within this expected range on the day.